Sector
PharmaceuticalsOpen
₹51.75Prev. Close
₹51.1Turnover(Lac.)
₹1.94Day's High
₹51.75Day's Low
₹48.5552 Week's High
₹68.3852 Week's Low
₹40.5Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
45.59P/E
26.97EPS
1.8Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 4.7 | 4.54 | 4.54 | 3.34 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 8.64 | 6.78 | 6.49 | 1.44 |
Net Worth | 13.34 | 11.32 | 11.03 | 4.78 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Dec-2020 | Mar-2020 |
---|---|---|---|
Revenue | 6.06 | 1.42 | 16.71 |
yoy growth (%) | 325.6 | -91.46 | |
Raw materials | -4.27 | -0.87 | -10.61 |
As % of sales | 70.41 | 61.16 | 63.48 |
Employee costs | -0.79 | -0.06 | -2.56 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Dec-2020 |
---|---|---|
Profit before tax | 0.16 | 0.3 |
Depreciation | -0.11 | -0.02 |
Tax paid | -0.01 | -0.07 |
Working capital | 0.57 | |
Other operating items |
Y/e 31 Mar | Mar-2021 | Dec-2020 |
---|---|---|
Growth matrix (%) | ||
Revenue growth | 325.6 | |
Op profit growth | 20.8 | |
EBIT growth | -3.64 | |
Net profit growth | -33.76 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 71.76 | 62.52 | 35.14 | 26.76 | 6.07 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 71.76 | 62.52 | 35.14 | 26.76 | 6.07 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.27 | 0.22 | 0.34 | 0.04 | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.6 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,484 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.1 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,164 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Kalpesh Pravinchandra Ladhawala
Whole-time Director
Tanmaykumar Ashwinbhai Shah
Executive Director & CFO
Sejal Ladhawala
Executive Director
Abhishekkumar Dineshkumar Patel
Executive Director
Fenil Prakashkumar Sha
Executive Director
Jigneshkumar Dineshkumar Modi
Executive Director
Krunal Jashubhai Patel
Executive Director
Nidhi YogeshKumar Shah
Independent Director
Jayshukh Ramjibhai Detroja
Independent Director
Rupesh Himatla Shah
Independent Director
Tapan Natverlal Patel
Independent Director
Nehalkumar Jasvantlal Shah
Company Sec. & Compli. Officer
Priyanka Shah
2nd Floor L5 377 Plot 5 Opp.,
Sabarmati Village: Khatraj,
Gujarat - 382721
Tel: 91-2764-66262
Website: http://www.walparnutritions.com
Email: finance.walpar@hotmail.com
D-153/A 1st Flr,
Okhla Industrial Are, Phase-I,
New Delhi-110020
Tel: 91-11-26812682
Website: www.skylinerta.com
Email: admin@skylinerta.com/virenr@skylinerta.com
Summary
Walpar Nutritions Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of M/s Walpar Healthcare, pursuant to a Deed of Partnership d...
Read More
Reports by Walpar Nutritions Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.